BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6318232)

  • 21. Evaluation of a novel antihypertensive agent, LY127210, in anesthetized and conscious spontaneously hypertensive rats.
    Ruffolo RR; Kurz K; Paget CJ
    J Pharmacol Exp Ther; 1985 Jan; 232(1):134-8. PubMed ID: 3838104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference of enantiomers of lofexidine with alpha-adrenoceptors.
    Wilffert B; Mathy MJ; Batink HD; de Jonge A; Thoolen MJ; Prop G; Graf E; Timmermans PB; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):18-32. PubMed ID: 2988468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic and myocardial blood flow. Profiles of pinacidil and nitroprusside in conscious dogs.
    Dubé GP; Greenfield JC
    Am J Hypertens; 1991 Feb; 4(2 Pt 1):144-50. PubMed ID: 2021445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective in vivo antagonism of pinacidil-induced hypotension by the guanidine U37883A in anesthetized rats.
    Smith MP; Humphrey SJ; Jackson WF
    Pharmacology; 1994 Dec; 49(6):363-75. PubMed ID: 7878074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between isoniazid and diverse vasodilators: role of decreased cerebral GABA.
    de los Angeles Sánchez-Salvatori M; Ríos C; Vidrio H
    Cardiovasc Res; 1998 Mar; 37(3):748-55. PubMed ID: 9659459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diuretic effect induced by intrarenal infusion of pinacidil in anesthetized dogs.
    Morimoto S; Matsumura Y; Sasaki Y; Takakuwa T; Kageyama M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1050-5. PubMed ID: 3656107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF; la Rochelle CD; Berdeaux A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between dilazep and alpha-adrenoceptors.
    Qian JQ; Batink HD; Timmermans PB; van Zwieten PA
    Pharmacology; 1984; 29(4):198-203. PubMed ID: 6149567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.
    Steinberg MI; Wiest SA; Zimmerman KM; Ertel PJ; Bemis KG; Robertson DW
    J Pharmacol Exp Ther; 1991 Jan; 256(1):222-9. PubMed ID: 1899116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat.
    Webb RL; McNeal RB; Barclay BW; Yasay GD
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1090-9. PubMed ID: 2203898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered renin release and propranolol potentiation of vasodilatory drug hypotension.
    Pettinger WA; Keeton K
    J Clin Invest; 1975 Feb; 55(2):236-43. PubMed ID: 236325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential renal vasodilator effects of CGP 22979A in conscious spontaneously hypertensive rats.
    Smits JF; Struyker-Boudier HA
    J Pharmacol Exp Ther; 1985 Mar; 232(3):845-9. PubMed ID: 3973832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction with pyridoxal as a possible mechanism of hydralazine hypotension.
    Vidrio H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):150-6. PubMed ID: 1688973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of urethane on hydralazine-induced tachycardia in rats.
    Orallo F; Fontenla JA; Loza MI; Campos M; Calleja JM
    Gen Pharmacol; 1992 Nov; 23(6):1143-7. PubMed ID: 1487125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pinacidil: history, basic pharmacology, and therapeutic implications.
    Ahnfelt-Rønne I
    J Cardiovasc Pharmacol; 1988; 12 Suppl 2():S1-4. PubMed ID: 2466172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and vascular activity of LY127210, a new vasodilator, in anesthetized spontaneously hypertensive rats: comparison with hydralazine.
    Steinberg MI; Keller CE; Bemis KG
    Clin Exp Hypertens A; 1985; 7(10):1481-97. PubMed ID: 3841035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.